USC Researchers Developed Noninvasive Brain Blood Flow Metric
A new MRI-based index improves understanding of how oxygen and glucose are delivered to specific layers of the human brain.
Updated on Sept. 19, 2026 in Stroke

Live Poll
Do you believe new brain imaging technologies will significantly improve the treatment of neurological conditions?
Researchers at USC have created the cerebral blood flow-cell-body staining intensity similarity index (CCSI) to track how blood perfusion matches cell density in the cerebral cortex. This noninvasive metric uses high-resolution imaging to identify metabolic needs that traditional brain scans previously averaged out.
Why it matters
Because brain tissue cannot store energy, it relies on precise blood flow for oxygen and glucose delivery to function correctly. This new metric provides a way to visualize specific layer-based metabolic requirements that were previously obscured by conventional neuroimaging techniques.
The CCSI metric utilizes data from a 7-Tesla MRI scanner and the 3D BigBrain digital atlas to analyze the cerebral cortex across 360 distinct parcels. The perfusion imaging achieves an isotropic spatial resolution of one cubic millimeter.
The players
USC
The University of Southern California is a leading private research university that houses the Stevens INI at its Keck School of Medicine.
Nature Communications
This peer-reviewed, open-access scientific journal publishes high-quality research from all areas of the natural sciences.
The details
The research team at the Keck School of Medicine used arterial spin labeling to magnetically tag water molecules, allowing them to map blood flow profiles against cell-body staining intensity. The resulting data tracks closely with capillary endothelial cells and mature oligodendrocytes, showing that high vascular-cellular alignment correlates with mitochondrial respiratory capacity.
Timeline
September 15, 2026: Study published in Nature Communications.
September 19, 2026: Article publication date.
The Big Picture
This study utilizes the 3D BigBrain digital atlas to bridge the gap between microscopic histology and macroscopic neuroimaging. By integrating these datasets, the researchers shift the paradigm from observing static anatomy to tracking dynamic vascular-cellular metabolic interactions.
The development of CCSI could eventually provide doctors with an early biomarker for identifying neurodegenerative or neurodevelopmental conditions. It paves the way for more precise monitoring of individual patient trajectories in future clinical practice.
The takeaway
This discovery demonstrates that the alignment between vascular supply and cellular density is a critical predictor of cognitive function in the human brain. Researchers plan to expand this work to evaluate how these metabolic patterns change in patients suffering from neurological disorders.
Further reading
For more information on the latest diagnostic advancements, visit the Stroke section.
More information
Read the complete Nature Communications open access research paper to understand the full methodology.
Source note: This article includes information reported by Neuroscience News.
Live Poll
Do you believe new brain imaging technologies will significantly improve the treatment of neurological conditions?










